Trial Outcomes

Automated Oxygen Titration Boosts Time in Target Saturation but Shows No Proven Clinical Benefit

The randomized SAVE-O2 AI trial found the investigational O2matic PRO100 device increased precision of oxygen delivery while remaining under FDA investigational oversight and needing more trials to show patient-centered benefit.